Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 13 November 1998:
Vol. 282. no. 5392, p. 1239
DOI: 10.1126/science.282.5392.1239a
Prev | Table of Contents | Next

News of the Week

BIOTECHNOLOGY:
Reaction to Stem Cells: A Tale of the Ticker

David Malakoff

Geron Corp. of Menlo Park, California, saw its stock price jump when company-supported researchers reported in Science and the Proceedings of the National Academy of Sciences that they have cultured "immortal" stem cells in the laboratory (Science, 6 November, pp. 1014 and 1145). The cells could potentially be used to repair damaged organs and tissues. But the price soon sank as investors realized that the scientifically interesting findings wouldn't soon lead to profitable products.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)